BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1412191)

  • 1. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K; Sakurai G; Baba M
    Thromb Res; 1992 May; 66(2-3):179-89. PubMed ID: 1412191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
    Stokol T; Brooks MB; Erb HN; Mauldin GE
    Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
    Stokol T; Erb HN; De Wilde L; Tornquist SJ; Brooks M
    Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
    Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
    Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
    Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS; Kim YA; Kim HK; Park Q
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
    Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
    Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between disseminated intravascular coagulation and levels of plasma thrombinogen segment 1+2, D-dimer, and thrombomodulin in patients with multiple injuries.
    Zhu YJ; Huang XK
    Chin J Traumatol; 2009 Aug; 12(4):203-9. PubMed ID: 19635212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a latex agglutination assay for FDP D-dimer to demonstrate the presence of postmortem blood.
    Sakurada K; Sakai I; Sekiguchi K; Shiraishi T; Ikegaya H; Yoshida K
    Int J Legal Med; 2005 May; 119(3):167-71. PubMed ID: 15654628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
    Gupta PK; Gupta M; Chatterjee T; Saxena R
    Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of a new latex photometric immunoassay reagent, LPIA-GENESIS D-dimer, and its performance in patient-derived plasma samples.
    Nagahama Y; Nozaki J; Sakurai G; Yajima S; Kaneko N; Yamazaki E; Matsuda M
    Int J Lab Hematol; 2020 Jun; 42(3):299-307. PubMed ID: 32112525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation.
    Park KJ; Kwon EH; Kim HJ; Kim SH
    Korean J Lab Med; 2011 Jul; 31(3):143-7. PubMed ID: 21779185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an immuno-turbidometric method (STalia D-DI) with an established enzyme linked fluorescent assay (VIDAS) D-dimer for the exclusion of venous thromboembolism.
    Sukhu K; Beavis J; Baker PM; Keeling DM
    Int J Lab Hematol; 2008 Jun; 30(3):200-4. PubMed ID: 18479298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
    Carr JM; McKinney M; McDonagh J
    Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
    Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
    Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.